Protalix BioTherapeutics, Inc.
Revenue Breakdown
| Fiscal Year | Selling of Goods | License and R&D |
|---|---|---|
| FY2006 | $0 | $1.4M |
| FY2007 | $0 | $1.4M |
| FY2008 | $0 | $1.4M |
| FY2013 | $31.2M | $0 |
| FY2015 | $4.4M | $0 |
| FY2016 | $9.2M | $169.0K |
| FY2017 | $18.4M | $2.4M |
| FY2018 | $19.1M | $14.2M |
| FY2019 | $16.9M | $37.6M |
| FY2021 | $16.5M | $21.8M |
| FY2023 | $51.8M | $15.5M |